{"transactions":[{"id":3857100,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":164644,"kind":"organization","name":"CD Financial, LLC","position":1,"cik":"0001443197","reported_name":"CD Financial, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"6% secured convertible note due 2020, as amended","published_at":"2018-08-01T21:33:30.000Z","date":"2018-07-24","kind":"exercise","acquired":false,"price":5350000,"reported_value":5350000,"ownership":{"direct":true},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"Common stock issued to the Reporting Person as the result of Reporting Person exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by the Reporting Person."},{"field":"reported_value","element":"transactionTotalValue","label":"F2","text":"On July 31, 2018, the Issuer issued 8,230,769 shares upon the receipt of a conversion notice from the Reporting Person settling the 6% secured convertible note in full."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock issued to the Reporting Person as the result of Reporting Person exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 31, 2018, the Issuer issued 8,230,769 shares upon the receipt of a conversion notice from the Reporting Person settling the 6% secured convertible note in full."}],"balance_after":0,"derivative":{"exercise_price":0.65,"exercise_date":"2012-06-27","expiration_date":"2020-02-20","underlying":"Common Stock","underlying_shares":8230769},"source":{"system":"sec-edgar","filing":"0001443197-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319718000001/primary_doc.xml","form_type":"4"}},{"id":3857099,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":164644,"kind":"organization","name":"CD Financial, LLC","position":1,"cik":"0001443197","reported_name":"CD Financial, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-01T21:33:30.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":8230769,"price":0.65,"value":5349999.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common stock issued to the Reporting Person as the result of Reporting Person exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by the Reporting Person."}],"balance_after":10524173,"source":{"system":"sec-edgar","filing":"0001443197-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319718000001/primary_doc.xml","form_type":"4"}}]}